Skip to main content
logo
Avadel Pharmaceuticals plc (AVDL)
21.64
+0.01 (0.05%)
Inactive · Last trade price on Feb 11, 2026

Avadel Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Market Cap
2,1241,0141,268450474390
Market Cap Growth
188.51%-20.02%181.72%-4.95%21.42%37.70%
Enterprise Value
2,070942.331,166484.73461.44299.21
Last Close Price
21.6410.5114.127.168.086.68

Price Ratios

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
PE Ratio
-----51.38
Forward PE
33.17200.19----
PS Ratio
8.426.0045.36--17.47
PB Ratio
21.4213.7414.46-21.296.052.40

EV Ratios

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
EV/Sales Ratio
8.335.5741.69--13.40
EV/EBITDA Ratio
766.89----39.87
EV/EBIT Ratio
-----51.46

Financial Efficiency

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Debt / Equity Ratio
0.030.020.03-6.201.850.80
Debt / EBITDA Ratio
0.31----17.39
Debt / FCF Ratio
0.07-----
Asset Turnover
1.371.030.19000.10
Inventory Turnover
0.571.000.16--3.22
Quick Ratio
2.142.213.181.777.6014.87
Current Ratio
2.762.753.641.819.1717.44
Return on Equity (ROE)
-0.32%-60.44%-481.35%-481.49%-64.30%10.56%
Return on Assets (ROA)
2.49%-25.65%-92.39%-63.98%-25.41%-3.47%
Return on Invested Capital (ROIC)
9.66%-127.05%-610.90%-252.56%-91.04%-11.31%
Return on Capital Employed (ROCE)
3.58%-34.86%-134.60%-65.00%-32.73%2.82%

Yields

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Earnings Yield
-----1.95%
Buyback Yield / Dilution
-3.42%-18.67%-33.41%-2.66%-6.54%-46.89%
Total Shareholder Return
-3.42%-18.67%-33.41%-2.66%-6.54%-46.89%
SEC Filings: 10-K · 10-Q